Compare monoclonal lab reagents for research






Suppliers for Lab recombinants

HCV-IN-4

TP1468-5mg TargetMol Chemicals 5mg
Description: HCV-IN-4

HCV-IN-31

112162 MedKoo Biosciences 1.0mg

HCV-IN-29

HY-136266 MedChemExpress 10 mg
Description: HCV-IN-29 is a hepatitis C virus (HCV) inhibitor exacted from patent US8329159B2, compound 1e[1].

HCV-IN-30

HY-136267 MedChemExpress 100 mg
Description: HCV-IN-30 (compound 48) is a HCV NS5A replication complex inhibitor, with IC50s of 901 and 102 nM for genotypes 1a and 1b replicons, respectively[1].

HCV-IN-31

HY-138305 MedChemExpress 10 mg
Description: HCV-IN-31 (compound 4) is a HCV inhibitor, with an EC50/EC95 of 15.7 μM for HCV replicon[1].

HCV Core 16.8kDa

hcv-011 ProSpec Tany 100µg
Description: Recombinant Hepatitis C Virus Nucleocapsid (core) 16,8kDa

HCV Core 169aa

hcv-012 ProSpec Tany 100µg
Description: Recombinant Hepatitis C Virus Nucleocapsid (core) 169aa

Polyclonal ETO polyclonal antibody

APR00372G Leading Biology 0.05ml 580.8 EUR

Polyclonal SHH Polyclonal Antibody

APR00434G Leading Biology 0.1mg 580.8 EUR

Polyclonal ETO polyclonal antibody

APR00435G Leading Biology 0.1ml 633.6 EUR

Polyclonal p53 polyclonal antibody

APR00443G Leading Biology 0.05mg 633.6 EUR

Polyclonal G9a polyclonal antibody

APR00448G Leading Biology 0.1ml 580.8 EUR

Polyclonal YY1 polyclonal antibody

APR14018G Leading Biology 0.1ml 580.8 EUR

Polyclonal PML polyclonal antibody

AMR09397G Leading Biology 0.05mg 580.8 EUR

Polyclonal RARA polyclonal antibody

APR00370G Leading Biology 0.05ml 580.8 EUR

Our used polyclonals in Pubmed.

Ly1 Antibody Reactive (LYAR) Antibody

abx311665-20g Abbexa 20 µg 162.5 EUR

Ly1 Antibody Reactive (LYAR) Antibody

abx311665-50g Abbexa 50 µg 250 EUR

Phospho-H2B (Y43) Antibody Antibody

E11-184359 EnoGene 100ug/100ul 225 EUR

Phospho-H2B (Y43) Antibody Antibody

MBS8528991-01mg MyBiosource 0.1mg 305 EUR

Phospho-H2B (Y43) Antibody Antibody

MBS8528991-01mLAF405L MyBiosource 0.1mL(AF405L) 465 EUR

Leave a Reply

Your email address will not be published. Required fields are marked *